Literature DB >> 1848258

Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats.

M Kuczera1, K F Hilgers, C Lisson, D Ganten, U Hilgenfeldt, E Ritz, J F Mann.   

Abstract

To examine and characterize the vascular renin--angiotensin system in low-renin models of renal hypertension with and without the presence of overt renal insufficiency, we studied the formation and metabolism of angiotensin in isolated perfused rat hindquarter preparations. Rats with 5/6 nephrectomy (5/6NX) and rats with one-kidney, one clip (1K1C) hypertension were compared to sham operated (sham) animals. Angiotensin peptides in plasma or perfusate were characterized by high-performance liquid chromatography and radioimmunoassay (RIA). Plasma angiotensin II was lower, and blood pressure was higher in both experimental groups, compared to sham animals. Plasma angiotensinogen, measured by both direct and indirect RIA, was increased in both experimental groups. The spontaneous release of angiotensin I and angiotensin II from perfused hindquarters did not differ between the groups. Angiotensin I conversion was not different in 5/6NX or 1K1C groups compared with controls. Furthermore, angiotensin conversion was completely inhibited by captopril (1 mumol/l) in all groups. Renin-induced angiotensin release was significantly increased in 5/6NX as compared with sham rats, whereas there was no difference in renin-induced angiotensin release between 1K1C and sham animals. Angiotensin II degradation was significantly attenuated in 5/6NX rats when compared with sham rats (27.6% versus 53.9%, respectively, P less than 0.05) but was unaltered in 1K1C rats. Thus, in chronic uremic hypertension, renin-induced angiotensin formation was increased in the face of decreased angiotensin II degradation. These data suggest that vascular angiotensin may contribute to the elevated blood pressure observed in chronic renal failure. In 1K1C rats, vascular angiotensin formation and metabolism was unchanged despite suppressed plasma angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848258

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

Review 1.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

2.  Pathophysiological, cardiovascular and neuroendocrine changes in hypertensive patients during the hemodialysis session.

Authors:  O A Gutiérrez-Adrianzén; M E A Moraes; A P Almeida; J W O Lima; M F Marinho; A L Marques; J P V Madeiro; L Nepomuceno; J M S da Silva; G B Silva; E F Daher; C R M Rodrigues Sobrinho
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

3.  The growth factor midkine regulates the renin-angiotensin system in mice.

Authors:  Akinori Hobo; Yukio Yuzawa; Tomoki Kosugi; Noritoshi Kato; Naoto Asai; Waichi Sato; Shoichi Maruyama; Yasuhiko Ito; Hiroyuki Kobori; Shinya Ikematsu; Akira Nishiyama; Seiichi Matsuo; Kenji Kadomatsu
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

4.  High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

Authors:  Karin Tyralla; Marcin Adamczak; Kerstin Benz; Valentina Campean; Marie-Luise Gross; Karl F Hilgers; Eberhard Ritz; Kerstin Amann
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.